<DOC>
	<DOCNO>NCT02479945</DOCNO>
	<brief_summary>The investigator compare tumor marker level , include PSA , sample take peripheral upper limb vein internal iliac vein . These collected patient schedule prostatectomy part standard care prostate cancer . A selective internal iliac vein sample procedure perform Interventional Radiology . Venous sample correlate prostatectomy specimen . The aim predict side prostate contain tumor .</brief_summary>
	<brief_title>Peripheral v . Selective Tumor Marker Venous Sampling Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>1 . All male patient , age 18 99 , biopsy proven prostate adenocarcinoma prior plan radical prostatectomy . 2 . Informed Consent/HIPAA Form discuss sign subject . 3 . Baseline lab value obtain within 120 day plan selective venous sampling . 1 . Skin related problem around plan venepuncture site ( infection , phlebitis , scar ) 2 . Documented allergy iodinate contrast lidocaine . 3 . Coagulopathy INR great 1.5 4 . Thrombocytopenia platelets less 25,000 uL 5 . Renal insufficiency creatinine 1.5 mg/dL 6 . Documented current upper extremity central venous thrombosis 7 . DRE within 4 week prior selective venous sample 8 . Prostate biopsy within 6 week prior selective venous sampling . 9 . Patient unable sign consent demonstrate full understanding procedure . 10 . Patient know metastatic disease know primary cancer prostate adenocarcinoma . 11 . Patient already enrol research study . 12 . Life expectancy le 6 month .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>